Jump to content

Mary Carrington: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Importing Wikidata short description: "American immunologist" (Shortdesc helper)
m not an orphan; in list article (via WP:JWB)
 
(13 intermediate revisions by 8 users not shown)
Line 1: Line 1:
{{short description|American immunologist}}
{{short description|American immunologist}}

{{Infobox scientist
{{Infobox scientist
| name = Mary Carrington
| name = Mary Carrington
Line 5: Line 6:
| alma_mater = [[University of Kansas]] (BS)<br>[[Iowa State University]] (MS, PhD)
| alma_mater = [[University of Kansas]] (BS)<br>[[Iowa State University]] (MS, PhD)
| workplaces = Duke University<br>[[Frederick National Laboratory for Cancer Research]]
| workplaces = Duke University<br>[[Frederick National Laboratory for Cancer Research]]
| image = M.Carrington.tif
}}
}}


Line 10: Line 12:


== Education ==
== Education ==
Carrington graduated from [[University of Kansas]] with a B.S. in Education, later obtaining her M.S. and Ph.D. in Immunobiology from [[Iowa State University]]. She performed her postdoctoral studies in the departments of Immunology and Microbiology at [[Duke University]] and the [[University of North Carolina]].<ref name=":0">{{Cite web|title=Mary Carrington, Ph.D. Frederick National Laboratory for Cancer Research|url=https://frederick.cancer.gov/science/staff/mary-carrington-phd|access-date=2020-07-25|website=frederick.cancer.gov}}{{PD-notice}}</ref>
Carrington graduated from [[University of Kansas]] with a B.S. in education, later obtaining her M.S. and Ph.D. in immunobiology from [[Iowa State University]]. She performed her postdoctoral studies in the departments of Immunology and Microbiology at [[Duke University]] and the [[University of North Carolina]].<ref name=":0">{{Cite web|title=Mary Carrington, Ph.D. Frederick National Laboratory for Cancer Research|url=https://frederick.cancer.gov/science/staff/mary-carrington-phd|access-date=2020-07-25|website=frederick.cancer.gov}}{{PD-notice}}</ref>


== Career and research ==
== Career and research ==
Carrington joined the Immunology Department at Duke University as a faculty member. She moved to the National Cancer Institute at Frederick in 1989. Carrington is the Director of the Basic Science Program at the [[Frederick National Laboratory for Cancer Research]], where she is responsible for the guidance and oversight of a large, diverse group of scientists performing investigator-initiated, hypothesis-driven basic research in cancer and AIDS. She is also a Senior Principal Scientist at the National Cancer Institute and heads the [[Human leukocyte antigen|Human Leukocyite Antigens]] Immunogenetics Laboratory in the Cancer and Inflammation Program. Her primary research interests focus on the role of host genetics in cancer, autoimmunity and infectious disease pathogenesis.<ref name=":0" /> Her group studies the influence of immunogenetic variation on risk of human disease, outcome to therapeutic treatment, and vaccination. These studies include elucidation of the functional basis for the genetic associations identified.<ref>{{Cite web|date=2014-08-12|title=Mary N. Carrington, Ph.D.|url=https://ccr.cancer.gov/Laboratory-of-Integrative-Cancer-Immunology/mary-n-carrington|access-date=2020-07-25|website=Center for Cancer Research|language=en}}{{PD-notice}}</ref>
Carrington joined the immunology department at Duke University as a faculty member. She moved to the National Cancer Institute at Frederick in 1989. Carrington is the director of the Basic Science Program at the [[Frederick National Laboratory for Cancer Research]], where she is responsible for the guidance and oversight of a large, diverse group of scientists performing investigator-initiated, hypothesis-driven basic research in cancer and AIDS. She is also a senior principal scientist at the National Cancer Institute and heads the [[Human leukocyte antigen|Human Leukocyite Antigens]] Immunogenetics Laboratory in the Cancer and Inflammation Program. Her primary research interests focus on the role of host genetics in cancer, autoimmunity and infectious disease pathogenesis.<ref name=":0" /> Her group studies the influence of immunogenetic variation on risk of human disease, outcome to therapeutic treatment, and vaccination. These studies include elucidation of the functional basis for the genetic associations identified.<ref>{{Cite web|date=2014-08-12|title=Mary N. Carrington, Ph.D.|url=https://ccr.cancer.gov/Laboratory-of-Integrative-Cancer-Immunology/mary-n-carrington|access-date=2020-07-25|website=Center for Cancer Research|language=en}}{{PD-notice}}</ref> In 2022, she was elected to the [[American Academy of Arts and Sciences]].<ref>{{Cite web |last=Glim |first=Melissa |date=2022-08-05 |title=Understanding the Foundations of Immune Defenses |url=https://irp.nih.gov/blog/post/2022/08/understanding-the-foundations-of-immune-defenses |access-date=2022-10-05 |website=NIH Intramural Research Program |language=en}}</ref>


== References ==
== References ==
Line 20: Line 22:


{{Authority control}}
{{Authority control}}
{{DEFAULTSORT:Carrington, Mary}}


{{DEFAULTSORT:Carrington, Mary}}
[[Category:Living people]]
[[Category:Living people]]
[[Category:Year of birth missing (living people)]]
[[Category:Year of birth missing (living people)]]
[[Category:Place of birth missing (living people)]]
[[Category:Place of birth missing (living people)]]
[[Category:American immunologists]]
[[Category:American immunologists]]
[[Category:Women immunologists]]
[[Category:American women immunologists]]
[[Category:20th-century American women scientists]]
[[Category:20th-century American women scientists]]
[[Category:21st-century American women scientists]]
[[Category:21st-century American women scientists]]
Line 32: Line 34:
[[Category:21st-century American biologists]]
[[Category:21st-century American biologists]]
[[Category:American medical researchers]]
[[Category:American medical researchers]]
[[Category:Women medical researchers]]
[[Category:American women medical researchers]]
[[Category:University of Kansas alumni]]
[[Category:University of Kansas alumni]]
[[Category:Iowa State University alumni]]
[[Category:Iowa State University alumni]]
[[Category:Duke University faculty]]
[[Category:Duke University School of Medicine faculty]]
[[Category:National Institutes of Health people]]
[[Category:National Institutes of Health people]]
[[Category:Fellows of the American Academy of Microbiology]]
[[Category:American women academics]]
[[Category:Fellows of the American Academy of Arts and Sciences]]

Latest revision as of 00:09, 11 April 2024

Mary Carrington
Alma materUniversity of Kansas (BS)
Iowa State University (MS, PhD)
Scientific career
FieldsImmunogenetics
InstitutionsDuke University
Frederick National Laboratory for Cancer Research

Mary N. Carrington is an American immunologist researching the role of host genetics in cancer, autoimmunity and infectious disease pathogenesis. She is director of the basic science program at the Frederick National Laboratory for Cancer Research.

Education

[edit]

Carrington graduated from University of Kansas with a B.S. in education, later obtaining her M.S. and Ph.D. in immunobiology from Iowa State University. She performed her postdoctoral studies in the departments of Immunology and Microbiology at Duke University and the University of North Carolina.[1]

Career and research

[edit]

Carrington joined the immunology department at Duke University as a faculty member. She moved to the National Cancer Institute at Frederick in 1989. Carrington is the director of the Basic Science Program at the Frederick National Laboratory for Cancer Research, where she is responsible for the guidance and oversight of a large, diverse group of scientists performing investigator-initiated, hypothesis-driven basic research in cancer and AIDS. She is also a senior principal scientist at the National Cancer Institute and heads the Human Leukocyite Antigens Immunogenetics Laboratory in the Cancer and Inflammation Program. Her primary research interests focus on the role of host genetics in cancer, autoimmunity and infectious disease pathogenesis.[1] Her group studies the influence of immunogenetic variation on risk of human disease, outcome to therapeutic treatment, and vaccination. These studies include elucidation of the functional basis for the genetic associations identified.[2] In 2022, she was elected to the American Academy of Arts and Sciences.[3]

References

[edit]
  1. ^ a b "Mary Carrington, Ph.D. Frederick National Laboratory for Cancer Research". frederick.cancer.gov. Retrieved 2020-07-25.Public Domain This article incorporates text from this source, which is in the public domain.
  2. ^ "Mary N. Carrington, Ph.D." Center for Cancer Research. 2014-08-12. Retrieved 2020-07-25.Public Domain This article incorporates text from this source, which is in the public domain.
  3. ^ Glim, Melissa (2022-08-05). "Understanding the Foundations of Immune Defenses". NIH Intramural Research Program. Retrieved 2022-10-05.
Public Domain This article incorporates public domain material from websites or documents of the National Institutes of Health.